Engineering a new cancer detection tool

June 8, 2017
cancer
Killer T cells surround a cancer cell. Credit: NIH

Studying the food poisoning bacteria E. coli may have led scientists to discover a new and improved tool to detect cancer.

In a collaborative research project, scientists from Griffith University's Institute for Glycomics, the University of Adelaide and University of Queensland have detailed their findings in a new paper published in Scientific Reports.

Professor Michael Jennings from the Institute for Glycomics said the E. coli produces a toxin which binds to an unusual sugar that is part of carbohydrate structures present on cells (Neu5Gc) which is not usually produced by .

"The structure that the toxin recognises is known to be a tumour antigen, that is, a substance produced by which are recognised markers for detection and diagnosis."

The research team then took the naturally-occurring toxin and engineered it to change the protein make-up so it became entirely specific to detecting only this singular tumour antigen structure.

"The real innovation here is that we have converted something that was discovered in an infectious disease research program into and were able to utilise it as a tool for potentially detecting tumour antigens," Professor Jennings said.

This tumour antigen is made by a wide range of cancers including breast and ovarian cancer.

"There's a saying in science that chance favours the prepared mind and because at the Institute we work with both infectious diseases and cancer research there was a cross fertilization of ideas and opportunity."

"We were very surprised at how well the engineering of this protein worked and we were able to remove the binding characteristics that were useless in a diagnostic sense and re-engineer it to make it totally specific for the antigen target," he said.

The Neu5Gc is expressed at very high levels on cancer cells but not normal so the discovery of Neu5Gc indicates the patient may be suffering cancer.

Humans are unable to make Neu5Gc but is absorbed into the human body through dietary intake of red meat and dairy.

Professor Jennings said more research has to be done but the important thing is this new tool has the potential to detect far more sensitively, a wide range of possible cancers.

Explore further: Tumor-trained T cells go on patrol

More information: Christopher J. Day et al, Structure aided design of a Neu5Gc specific lectin, Scientific Reports (2017). DOI: 10.1038/s41598-017-01522-9

Related Stories

Tumor-trained T cells go on patrol

May 15, 2017

'Tumour-trained' immune cells - which have the potential to kill cancer cells - have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Australia's Garvan ...

Recommended for you

Cancer hijacks natural cell process to survive

June 26, 2017

Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by the University of Oxford.

Targeted drug shows promise in rare advanced kidney cancer

June 23, 2017

Some patients with a form of advanced kidney cancer that carries a poor prognosis benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth, according to research led by a Dana-Farber ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.